Evidence for NADPH oxidase activation by GPR40 in pancreatic β-cells
Open Access
- 1 December 2020
- journal article
- research article
- Published by Taylor & Francis in Redox Report
- Vol. 25 (1) , 41-50
Abstract
Objective: Investigate the involvement of the fatty acids receptor GPR40 in the assembly and activation of NADPH oxidase and the implications on pancreatic β-cell function. Methods: BRIN-BD11 β-cells were exposed to GPR40 agonist (GW9508) or linoleic acid in different glucose concentrations. Superoxide and H2O2 were analyzed, respectively, by DHE fluorescence and by fluorescence of the H2O2 sensor, roGFP2-Orp1. Protein contents of p47phox in plasma membrane and cytosol were analyzed by western blot. NADPH oxidase role was evaluated by p22phox siRNA or by pharmacological inhibition with VAS2870. NOX2 KO islets were used to measure total cytosolic calcium and insulin secretion. Results: GW9508 and linoleic acid increased superoxide and H2O2 contents at 5.6 and 8.3 mM of glucose. In addition, in 5.6 mM, but not at 16.7 mM of glucose, activation of GPR40 led to the translocation of p47phox to the plasma membrane. Knockdown of p22phox abolished the increase in superoxide after GW9508 and linoleic acid. No differences in insulin secretion were found between wild type and NOX2 KO islets treated with GW9508 or linoleic acid. Discussion: We report for the first time that acute activation of GPR40 leads to NADPH oxidase activation in pancreatic β-cells, without impact on insulin secretion.Keywords
Funding Information
- FAPESP (2009/53661-2 and 2009/51893-0)
This publication has 60 references indexed in Scilit:
- Randomized, Double-Blind, Dose-Ranging Study of TAK-875, a Novel GPR40 Agonist, in Japanese Patients With Inadequately Controlled Type 2 DiabetesDiabetes Care, 2013
- TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trialThe Lancet, 2012
- ROS-induced ROS release in vascular biology: redox-redox signalingAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Regulation of insulin secretion and reactive oxygen species production by free fatty acids in pancreatic isletsIslets, 2011
- Control of the Intracellular Redox State by Glucose Participates in the Insulin Secretion MechanismPLOS ONE, 2011
- Peroxisome-Generated Hydrogen Peroxide as Important Mediator of Lipotoxicity in Insulin-Producing CellsDiabetes, 2010
- G-protein-coupled receptor 40 (GPR40) expression and its regulation in human pancreatic islets: The role of type 2 diabetes and fatty acidsNutrition, Metabolism and Cardiovascular Diseases, 2010
- Palmitate-Induced β-Cell Dysfunction Is Associated with Excessive NO Production and Is Reversed by Thiazolidinedione-Mediated Inhibition of GPR40 Transduction MechanismsPLOS ONE, 2008
- Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small moleculesBritish Journal of Pharmacology, 2006
- Role of GPR40 in fatty acid action on the β cell line INS-1EBiochemical and Biophysical Research Communications, 2005